Angioplasty or bare metal stent versus drug-eluting endovascular treatment in femoropopliteal artery disease: a systematic review and meta-analysis.

CONCLUSIONS: While confirming that DCB outperforms POBA in terms of primary patency and TLR at 12 months, only TLR benefits are noted for DES vs BMS and DCB vs DES in limited clinical settings. Further RCTs are needed to strongly assess the compared performance of drug eluting devices in relation to lesion length and controlling possible confounders.
PMID: 31527577 [PubMed - as supplied by publisher]

Source: The Journal of Cardiovascular Surgery - September 12, 2019 Category: Cardiovascular & Thoracic Surgery Authors: Varetto G, Gibello L, Boero M, Frola E, Peretti T, Spalla F, Verzini F, Rispoli P Tags: J Cardiovasc Surg (Torino) Source Type: research